FDA eyes first schizophrenia drug shift in decades - Axios

1. FDA eyes first schizophrenia drug shift in decades  Axios
2. Will 'Game Changer' Antipsychotic Live Up to the Hype?  Medscape
3. Schizophrenia Space Anticipates First-in-Class FDA Approval for BMS’ KarXT  BioSpace
4. Schizophrenia: the new drug set to tackle the ‘cancer of psychiatry’  Financial Times
5. The 'game-changing' treatment for schizophrenia  The Week